MAPT and Alzheimer disease: • Aβ42 decreased in CAA vs. controls but not AD• Aβ40 CAA decreased in CAA vs. AD but not controls• T-tau decreased in CAA vs. AD, decreased in CAA vs. controls• P-tau181 increased in CAA vs. AD but not controls